Article metrics
Other content recommended for you
- Financial interests of patient organisations contributing to technology assessment at England’s National Institute for Health and Care Excellence: policy review
- Exposing drug industry funding of UK patient organisations
- Cancer patients’ organisation participation in heath policy decision-making: a snapshot/cluster analysis of the EU-28 countries
- Industry funding of patient organisations in the UK: a retrospective study of commercial determinants, funding concentration and disease prevalence
- Patient and public involvement in the benefit–risk assessment and decision concerning health products: position of the Scientific Advisory Board of the French National Agency for Medicines and Health Products Safety (ANSM)
- Is the international regulation of medical complicity with torture largely window dressing? The case of Israel and the lessons of a 12-year medical ethical appeal
- Association between medical complications according to continuity of care and medication adherence in patients with hypertension in Korea: a national population-based cohort study
- Patient–physician collaboration in rheumatology: a necessity
- 2021 EULAR recommendations for the implementation of self-management strategies in patients with inflammatory arthritis
- Reducing the risk of NHS disasters